Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

STI & HIV World Congress 2023

Chicago, IL USA

24.07.2023

New developments in the response to AMR STIs: surveillance efforts, new treatments and diagnostics and better strategies for LMICs

In response to the rise of STIs and antimicrobial resistance, experts around the world have doubled efforts to bring innovation in the prevention, diagnosis, and treatment of STIs. New advances in STI treatments and diagnostics still need to be implemented. This session will present some of the latest developments in the field, share experiences from LMICs and chart the way forward.

Overview

  • Setting up the scene, surveillance and EGASP summary – Teodora Wi, WHO
  • Imagine the world in 10-15 years if we did nothing today on NG-AMR – TBC
  • Challenges in implementing STI control programmes : key challenges including AMR and innovative solutions – Chido Dzivachikwari (Zimbabwe), Rossaphorn Kittiyaowamarn (Thailand) and Pamela Gaspar (Brazil)
  • Diagnostic development – Cecilia Ferreyra, FIND
  • Antibiotic development – Fernando Pascual, GARDP

Programme of the event